NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	type 2 diabetes
Date of first enrollment	20/08/2010
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : OPC-262 INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : orally once daily

Outcome(s)

Primary Outcome	Safety
Secondary Outcome	HbA1c Change from baseline in HbA1c

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	1) Patients who are capable of giving informed consent 2) Patients who are able to take contraceptive measures to avoid pregnancy of the patient or the patient's partner
Exclude criteria	Patients with severe ketosis, diabetic coma or precoma, or type 1 diabetes mellitus